DOAJ Open Access 2021

Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?

Sanna Laurila Sanna Laurila Sanna Laurila Eleni Rebelos Miikka-Juhani Honka +2 lainnya

Abstrak

Secretin is the first hormone that has been discovered, inaugurating the era and the field of endocrinology. Despite the initial focus, the interest in its actions faded away over the decades. However, there is mounting evidence regarding the pleiotropic beneficial effects of secretin on whole-body homeostasis. In this review, we discuss the evidence from preclinical and clinical studies based on which secretin may have a role in the treatment of obesity.

Topik & Kata Kunci

Diseases of the endocrine glands. Clinical endocrinology

Penulis (7)

Sanna Laurila

Eleni Rebelos

Miikka-Juhani Honka

Pirjo Nuutila

Format Sitasi

APA MLA BibTeX

Laurila, S., Laurila, S., Laurila, S., Rebelos, E., Honka, M., Nuutila, P. et al. (2021). Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?. https://doi.org/10.3389/fendo.2021.737686

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.3389/fendo.2021.737686

Informasi Jurnal

Tahun Terbit: 2021
Sumber Database: DOAJ
DOI: 10.3389/fendo.2021.737686
Akses: Open Access ✓